openPR Logo
Press release

Explosive Growth in Pimavanserin Market: Industry to Expand from USD 2.67 Billion in 2024 to USD 6.7 Billion by 2032, Driven by 12.2% CAGR

09-03-2024 05:49 PM CET | Health & Medicine

Press release from: WiseGuy Reports

/ PR Agency: WiseGuy Reports
Pimavanserin Market

Pimavanserin Market

In 2023, the pimavanserin market size was projected to be 2.38 billion USD. It is anticipated that the pimavanserin market industry would increase from 2.67 (USD billion) in 2024 to 6.7 (USD billion) by 2032. Over the projection period (2024 - 2032), the Pimavanserin Market CAGR (growth rate) is anticipated to be approximately 12.2%.

Market Trends

The Pimavanserin Market is witnessing a growing focus on the development of new formulations and extended indications. Pharmaceutical companies are investing in research to expand the use of pimavanserin beyond Parkinson's disease psychosis, exploring its potential in treating Alzheimer's disease-related psychosis and schizophrenia. Additionally, the increasing adoption of precision medicine is driving the demand for targeted therapies like pimavanserin. As awareness of mental health disorders rises globally, there is a growing acceptance of novel antipsychotic treatments, further fueling market growth.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report: https://www.wiseguyreports.com/sample-request?id=591486

Market Drivers

The primary driver of the Pimavanserin Market is the rising prevalence of neurodegenerative and psychiatric disorders, particularly Parkinson's disease and dementia-related psychosis. As the global population ages, the incidence of these conditions is expected to increase, boosting the demand for effective treatments like pimavanserin. Additionally, the drug's unique mechanism of action, which targets serotonin receptors without affecting dopamine pathways, makes it a preferred option for managing psychosis in elderly patients. Regulatory approvals and ongoing clinical trials for expanded indications also contribute to market growth.

Market Restraints

Despite its potential, the Pimavanserin Market faces several restraints, including high treatment costs, which can limit accessibility, especially in low-income regions. Concerns regarding the drug's side effects, such as increased mortality in elderly patients with dementia-related psychosis, have also led to cautious adoption in some markets. Additionally, competition from other antipsychotic medications, including both generic and branded options, poses a challenge to the market's growth. Regulatory hurdles and the lengthy process of gaining approvals for new indications further impede the market's expansion.

Pimavanserin Market Segmentation Insights

Pimavanserin Market Indication Outlook

Parkinson's Disease Psychosis

Alzheimer's Disease Psychosis

Other

Pimavanserin Market Administration Route Outlook

Oral

Injectable

Pimavanserin Market Distribution Channel Outlook

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Pimavanserin Market Dosage Form Outlook

Tablets

Capsules

Liquid Solutions

Buy Now Premium Research Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=591486

The Pimavanserin market shows promising regional growth, particularly in North America, driven by high awareness and the presence of key players. The United States dominates due to the increasing prevalence of Parkinson's disease and related psychosis. Europe follows, with significant growth in countries like Germany and the UK, supported by advanced healthcare infrastructure and research initiatives. The Asia-Pacific region is expected to witness rapid expansion, fueled by growing healthcare investments, increasing diagnosis rates, and a large elderly population. Emerging markets in Latin America and the Middle East also present growth opportunities due to improving healthcare access and rising demand.

Key Companies in the Pimavanserin Market Include:

AstraZeneca Plc
Amgen Inc.
Merck Co., Inc.
ACADIA Pharmaceuticals Inc.
Pfizer Inc.
Novartis AG
Sanofi S.A.
AbbVie Inc.
Johnson Johnson Services, Inc.
Roche Holding AG
Biogen Inc.
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Otsuka Pharmaceutical Co., Ltd.
Eisai Co., Ltd.
Key Questions delivered by Analysing study of Pimavanserin Market

What are the primary growth drivers influencing the Pimavanserin market?
How is the competitive landscape shaping up for Pimavanserin manufacturers?
What are the key challenges faced by market players in the Pimavanserin market?
Which regions are expected to show the highest growth in Pimavanserin demand?
How are regulatory changes impacting the Pimavanserin market?
What are the latest trends in innovation and product development within the Pimavanserin market?
Browse Premium Research insights: https://www.wiseguyreports.com/reports/pimavanserin-market

Table of Contents

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS

EXECUTIVE SUMMARY

Market Overview

Key Findings

Market Segmentation

Competitive Landscape

Challenges and Opportunities

Future Outlook

SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE

MARKET INTRODUCTION

Definition

Scope of the study

Research Objective

Assumption

Limitations

RESEARCH METHODOLOGY

Overview

Data Mining

Secondary Research

Primary Research

Primary Interviews and Information Gathering Process

Breakdown of Primary Respondents

Forecasting Model

Market Size Estimation

Bottom-Up Approach

Top-Down Approach

Data Triangulation

Validation… and More

Other Related Reports:

Freund Adjuvant Market: https://www.wiseguyreports.com/reports/freund-adjuvant-market

Gadolinium Contrast Medium Market: https://www.wiseguyreports.com/reports/gadolinium-contrast-medium-market

Eye Spear Market: https://www.wiseguyreports.com/reports/eye-spear-market

Emergency Tourniquets Market: https://www.wiseguyreports.com/reports/emergency-tourniquets-market

Experimental Rat Market: https://www.wiseguyreports.com/reports/experimental-rat-market

Genetic Services Market: https://www.wiseguyreports.com/reports/genetic-services-market

Estrogen Receptor Beta Market: https://www.wiseguyreports.com/reports/estrogen-receptor-beta-market

Fall Prevention Monitor Market: https://www.wiseguyreports.com/reports/fall-prevention-monitor-market

Goat Anti Mouse Igg Antibody Market: https://www.wiseguyreports.com/reports/goat-anti-mouse-igg-antibody-market

Glass Cartridge Market: https://www.wiseguyreports.com/reports/glass-cartridge-market

Foldable Electric Wheelchairs Market: https://www.wiseguyreports.com/reports/foldable-electric-wheelchairs-market

Exam Gown Market: https://www.wiseguyreports.com/reports/exam-gown-market

Emergency Bandage Market: https://www.wiseguyreports.com/reports/emergency-bandage-market

Genetically Modified Mouse Market: https://www.wiseguyreports.com/reports/genetically-modified-mouse-market

Gilenya Market: https://www.wiseguyreports.com/reports/gilenya-market

About US:
Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets.

WiseGuy Reports
Pune Maharashtra, India 411028
+91 20 6912 2998 | +162 825 80070 (US) | +44 203 500 2763 (UK)

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Explosive Growth in Pimavanserin Market: Industry to Expand from USD 2.67 Billion in 2024 to USD 6.7 Billion by 2032, Driven by 12.2% CAGR here

News-ID: 3644159 • Views:

More Releases from WiseGuy Reports

Hair Transplant Market Anticipated to Reach USD 15.65 Billion, at a Notable 6.24% CAGR by 2035
Hair Transplant Market Anticipated to Reach USD 15.65 Billion, at a Notable 6.24 …
Rising Confidence: How the Hair Transplant Market Is Transforming Personal Aesthetics The Hair Transplant Market is experiencing a significant boom as more individuals seek effective and permanent solutions to hair loss. Once considered a niche cosmetic procedure, hair transplantation has entered the mainstream, driven by technological advancements, changing perceptions around appearance, and growing awareness of treatment availability. The Hair Transplant Market is on a remarkable growth path, reflecting the global rise in
Cell Free In Vitro System Market Growth: Regional Insights and Emerging Business Trends through 2032
Cell Free In Vitro System Market Growth: Regional Insights and Emerging Business …
The Cell Free In Vitro System Market research report provides important information about the industry's evolution, emphasizing the primary growth drivers and revenue streams anticipated between 2024 and 2032. It aids companies in navigating the intricacies of the market by highlighting both the current state of affairs and the most recent advancements impacting its course, much like a compass. This report is a strategic ally for businesses, stakeholders, and industry
Wound Care Adhesives Market Poised for Surprising Growth: Key Outlook and Regional Forecast to 2032
Wound Care Adhesives Market Poised for Surprising Growth: Key Outlook and Region …
A New report from the WGR, titled Wound Care Adhesives Market Report 2024 Market Size, Trends, and Global Forecast 2024-2032, offers a thorough analysis of the market's changing trends, investment opportunities, and competitive landscape. By the end of 2032, the Wound Care Adhesives market trends will be valued at USD 35 Billion, per a WGR analysis. Furthermore, the report projects that the Wound Care Adhesives market trends will grow at
Veterinary Healthcare For Livestock Animals Market Trends: Surprising Growth and Business Opportunities Forecast to 2032
Veterinary Healthcare For Livestock Animals Market Trends: Surprising Growth and …
The Veterinary Healthcare For Livestock Animals Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as a strategic ally

All 5 Releases


More Releases for Pimavanserin

Psychosis in Parkinson's and Alzheimer's Disease Market: Epidemiology, Pipeline …
According to DelveInsight's analysis, the psychosis in Parkinson's disease and Alzheimer's disease market in the 7MM was valued at approximately USD 1,290 million in 2023 and is projected to grow over the forecast period from 2024 to 2034. Emerging therapies for psychosis in Parkinson's and Alzheimer's disease, including NUPLAZID (pimavanserin), Ulotaront (SEP-363856), KarXT (xanomeline-trospium), ITI-1284, and others, are expected to drive significant growth in the market in the coming years. DelveInsight has
Pimavanserin Market Size And Global Industry Forecast 2034
" The global Pimavanserin market is valued at approximately $1.2 billion in 2024, with projections indicating significant growth, anticipating a market value of around $3.5 billion by 2034. This reflects a Compound Annual Growth Rate (CAGR) of approximately 12% over the forecast period from 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Pimavanserin Market". This report covers the global Pimavanserin market sales, sales volume, price, market share,
Psychosis in Parkinson's and Alzheimer's Disease Market: Analysis of Epidemiolog …
Psychosis in Parkinson's and Alzheimer's Disease emerging therapies such as NUPLAZID (pimavanserin), Ulotaront (SEP-363856), KarXT (xanomeline-trospium), ITI-1284, and others are expected to boost the Psychosis in Parkinson's and Alzheimer's Disease Market in the upcoming years. DelveInsight has launched a new report on "Psychosis in Parkinson's and Alzheimer's Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Psychosis in Parkinson's and Alzheimer's Disease, historical and forecasted
Tetrahydropalmatine Hydrochloride Market Grows: Rising Demand for Natural Remedi …
LOS ANGELES, United States - The global Tetrahydropalmatine Hydrochloride market is undergoing a transformative phase, driven by a range of factors that are reshaping the landscape for market participants. Our latest research report offers a comprehensive analysis that enables businesses to secure a competitive edge in this dynamic industry. The Tetrahydropalmatine Hydrochloride report delves into pivotal market forces, including growth drivers, constraints, emerging trends, and opportunities, equipping businesses with the
Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc.. Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA
Deadline on June 18th coming up in Lawsuit for Investors in ACADIA Pharmaceutica …
A deadline is coming up on June 18, 2021 in the lawsuit filed for certain investors of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) over alleged securities laws violations by ACADIA Pharmaceuticals Inc. Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and there are strict and short deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -